Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

December 13, 2016December 13, 2016

Treatment Against Mycobacterium Abscessus May Improve Bronchiectasis, Case Study Suggests

News

Antibiotic treatments against lung infections by the bacteria Mycobacterium abscessus can improve the outcome of patients with bronchiectasis, according to a new study. The case study “Eradication Of Mycobacterium Abscessus ... Read more

December 6, 2016February 16, 2017

Pulmaquin Shows Promise for Non-CF Bronchiectasis Patients with Lung Infections

News

Results from two Phase 3 studies show that Pulmaquin (inhaled ciprofloxacin) may be a safe and effective therapy for patients with non-cystic fibrosis bronchiectasis (non-CF BE) with chronic lung infections ... Read more

November 8, 2016November 8, 2016

Study Review Shows Several Associations Between Bronchiectasis, COPD

News

A recent study review published in the Chinese Medical Journal highlighted associations between bronchiectasis and chronic obstructive pulmonary disease (COPD). The review, “Bronchiectasis As A Comorbidity Of Chronic Obstructive Pulmonary Disease: ... Read more

November 3, 2016November 3, 2016

Case Report Suggests Diffuse Bronchiectasis May Develop from Sarcoidosis

News

Non-cystic fibrosis (CF) bronchiectasis may develop as the primary manifestation of endobronchial sarcoidosis, a disease that affects the lungs’ bronchi (the tiny sacs that make up the lungs, where respiratory ... Read more

October 19, 2016October 19, 2016

#CHEST2016 – Bayer to Present Data from Phase 3 Trial on Non-CF Bronchiectasis Therapy

News

Bayer will present data from current trials in non-cystic fibrosis (non-CF) bronchiectasis and pulmonary arterial hypertension at the American College of Chest Physicians (CHEST 2016) Oct. 22-26 in Los Angeles. “Our data reflects Bayer’s ... Read more

October 13, 2016October 13, 2016

Treatments for Lung Infections Caused by Biofilms Goal of Aradigm Partnership

News

Aradigm Corporation announced a collaboration with the University of Sydney to develop a program of advanced nanotechnologies to treat bacterial and fungal biofilms — aggregates of pathogens that adhere and ... Read more